Stem-Cell Therapy Reverses Type 1 Diabetes in Groundbreaking Case Study

Translate to Spanish or other 102 languages!

A woman with type 1 diabetes started producing her own insulin less than 3 months after receiving an injection of a stem-cell derived treatment. She remained free from insulin injections 1 year after treatment. Image for illustrator purposes
A woman with type 1 diabetes started producing her own insulin less than 3 months after receiving an injection of a stem-cell derived treatment. She remained free from insulin injections 1 year after treatment. Image for illustrator purposes
- Advertisement -
  • A woman has undergone a stem-cell therapy made from her own cells, to treat her type 1 diabetes. 
  • Researchers in China discovered the woman did not need to use insulin 75 days after the procedure, and that the stem-cell derived islet cells she was injected with had been engrafted inside her abdomen. 
  • More people have been enrolled in this trial and other stem-cell therapy trials at several sites around the world. 

A woman with type 1 diabetes started producing her own insulin less than 3 months after receiving an injection of a stem-cell derived treatment. She remained free from insulin injections 1 year after treatment.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/stem-cell-therapy-reverses-type-1-diabetes-in-groundbreaking-case-study?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-04&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.

Three Everyday Habits That Could Be Ruining Your Sleep

 If you struggle to get a good night’s sleep, you may want to look at some of your habits – like what time you actually go to bed.

When GLP‑1s Fall Short

Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonistsTrusted Source have been growing in popularity for not only treating type 2 diabetes but also for weight loss. 
- Advertisement -